Director Process Engineering (Manufacturing Science & Technology) & Project Management at Aesica Pharmaceuticals GmbH (Recipharm) in Zwickau
ABOUT THE ROLE
Reporting to the Global Head of MSAT and PM, the Director of MSAT and PM will take responsibility for Process development and installation and validation of new equipment for Recipharm’s sites in Monheim and Zwickau.
This role will be part of the Site Leadership Team.
MAIN TASKS & RESPONSIBILITIES
MSAT tasks
Project Management tasks
EXPERIENCE
SKILLS
LOCATION
The role is located at the Zwickau site or possibly Monheim am Rhein site, with the option of hybrid working available.
This position may require some in-country and Global travel.
WHAT WE OFFER
Our core values of Respect, Reliability, Collaboration and Excellence shape every aspect of our work and our interactions with all our stakeholders. We seek individuals who are respectful, considerate and honest, value diversity and show integrity in their daily work. Our culture thrives on reliability, ensuring we consistently deliver on our promises and meet the expectations of our stakeholders through operational excellence. We believe in the power of collaboration, fostering an agile environment through teamwork and active listening. Our relentless pursuit of excellence drives us to deliver high-quality products and services, while maintaining a supportive and inclusive atmosphere where every team member is recognised and valued. Join us to be part of a community that is committed to mutual success and high standards.
ABOUT RECIPHARM
Recipharm is a leading Contract Development and Manufacturing Organisation (CDMO) employing over 5,900 employees worldwide. Recipharm provides manufacturing services of pharmaceuticals in various dosage forms, including, sterile fill & finish, oral solid dosage and biologics; clinical trial material development and manufacturing services; and, pharmaceutical product development. Its biologics segment, ReciBioPharm, works with customers to develop and commercialise advanced therapy medicinal products (ATMPs): pre-clinical to clinical and commercial development and manufacture for new biological modalities, encompassing technologies based on live viruses and viral vectors, live-microbial biopharmaceutical products, nucleic acid-based mRNA and plasmid DNA production.
Recipharm manufactures several hundred different products to customers ranging from big pharma to smaller research and development companies. It operates development and manufacturing facilities in France, Germany, India, Israel, Italy, Portugal, Spain, Sweden and the US and is headquartered in Stockholm, Sweden.
For more information on Recipharm and our services, please visit www.recipharm.com and www.recibiopharm.com